日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Healing Through History: a qualitative evaluation of a social medicine consultation curriculum for internal medicine residents

历史疗愈：一项针对内科住院医师的社会医学咨询课程的定性评估

期刊:BMC Medical Education
影响因子:3.2
doi:10.1186/s12909-021-02505-1
Bradley, Joel; Styren, David; LaPlante, Abigail; Howe, John; Craig, Sienna R; Cohen, Emily
发表日期：2021
文献求助 收藏

Two microcephaly-associated novel missense mutations in CASK specifically disrupt the CASK-neurexin interaction

CASK 中的两个与小头畸形相关的新型错义突变特异性地破坏了 CASK-神经连接蛋白的相互作用

期刊:Human Genetics
影响因子:3.8
doi:10.1007/s00439-018-1874-3
Leslie E W LaConte, Vrushali Chavan, Abdallah F Elias, Cynthia Hudson, Corbin Schwanke, Katie Styren, Jonathan Shoof, Fernando Kok, Sarika Srivastava, Konark Mukherjee
神经
Neuron medium
发表日期：2018
文献求助 收藏

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy

多剂量ponezumab治疗轻度至中度阿尔茨海默病：安全性和有效性

期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1016/j.trci.2017.04.003
Landen, Jaren W; Cohen, Sharon; Billing, Clare B Jr; Cronenberger, Carol; Styren, Scot; Burstein, Aaron H; Sattler, Catherine; Lee, Jae-Hong; Jack, Clifford R Jr; Kantarci, Kejal; Schwartz, Pamela F; Duggan, William T; Zhao, Qinying; Sprenger, Ken; Bednar, Martin M; Binneman, Brendon
阿尔茨海默症
发表日期：2017
文献求助 收藏

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies

两项3期扩展研究评估了bapineuzumab在阿尔茨海默病患者中的长期安全性和耐受性

期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-016-0193-y
Ivanoiu, Adrian; Pariente, Jérémie; Booth, Kevin; Lobello, Kasia; Luscan, Gerald; Hua, Lisa; Lucas, Prisca; Styren, Scot; Yang, Lingfeng; Li, David; Black, Ronald S; Brashear, H Robert; McRae, Thomas
阿尔茨海默症
发表日期：2016
文献求助 收藏

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab

阿尔茨海默病评估量表-认知11项进展模型在巴比妥单抗治疗轻度至中度阿尔茨海默病的试验中的应用

期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1016/j.trci.2015.09.001
Samtani, Mahesh N; Xu, Steven X; Russu, Alberto; Adedokun, Omoniyi J; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H Robert; Styren, Scot; Hu, Chuanpu
阿尔茨海默症
神经科学
发表日期：2015
文献求助 收藏

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials

利用巴比妥单抗试验中痴呆症残疾评估评分构建阿尔茨海默病进展模型

期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1016/j.trci.2015.06.005
Xu, Steven X; Samtani, Mahesh N; Russu, Alberto; Adedokun, Omoniyi J; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H Robert; Styren, Scot; Hu, Chuanpu
阿尔茨海默症
发表日期：2015
文献求助 收藏

The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury

型白细胞介素-1 受体对于有效激活小胶质细胞和诱导脑损伤引起的多种促炎介质至关重要

期刊:Journal of Neuroscience
影响因子:4.4
doi:10.1523/JNEUROSCI.22-14-06071.2002
Anirban Basu, J Kyle Krady, Mark O'Malley, Scott D Styren, Steven T DeKosky, Steven W Levison
免疫
细胞生物学
胶质细胞
发表日期：2002
文献求助 收藏

Complement activation by beta-amyloid in Alzheimer disease

阿尔茨海默病中β-淀粉样蛋白激活补体

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.89.21.10016
Rogers, J; Cooper, N R; Webster, S; Schultz, J; McGeer, P L; Styren, S D; Civin, W H; Brachova, L; Bradt, B; Ward, P
阿尔茨海默症
免疫/内分泌
发表日期：1992
文献求助 收藏